CBT and GET Database - HFME

After completing the three phases, the manufacturer submits the data on safety and effectiveness to Health Canada or to the FDA in an application for license to sell the product. Health Canada has the responsibility to review the clinical studies data, the available facilities, and the methods used for manufacturing the product. ................
................